Keywords: BioCryst Pharma, Presidio Pharma, Merger concelled, Pfizer, Nestle, Nutrition business, Teva, Acquisition plans, Financial guidance

M&A briefs: BioCryst/Presidio; Pfizer/Nestle; Teva

Article | 03 December 2012

Print This

Shares of USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX) saw its shares rocket as much as 80%, before levelling out and closing Friday ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in